Strategic paths for biomarker qualification

This publication has 8 references indexed in Scilit:

• Implementing the U.S. FDA guidance on pharmacogenomic data submissions
  Environmental and Molecular Mutagenesis, 2007
• Biomarker qualification pilot process at the US Food and Drug Administration
  The AAPS Journal, 2007
• The Experience with Voluntary Genomic Data Submissions at the FDA and a Vision for the Future of the Voluntary Data Submission Program
  Clinical Pharmacology & Therapeutics, 2007
• Biomarkers and Surrogate End Points for Fit-for-Purpose Development and Regulatory Evaluation of New Drugs
  Clinical Pharmacology & Therapeutics, 2007
• Process Map Proposal for the Validation of Genomic Biomarkers
  Pharmacogenomics, 2006
• Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement
  Pharmaceutical Research, 2006
• The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): A Review of the ICCVAM Test Method Evaluation Process and Current International Collaborations with the European Centre for the Validation of Alternative Methods (ECVAM)
  Alternatives to Laboratory Animals, 2002
• Use of Biomarkers and Surrogate Endpoints in Drug Development and Regulatory Decision Making: Criteria, Validation, Strategies
  Annual Review of Pharmacology and Toxicology, 2001